China Pharma Holdings Inc (CPHI) Technical Analysis
$1.85▲1.65%
Market is closed - opens 7 PM, 16 Sep 2025
Insights
- China Pharma is currently not in a favorable trading position ( SELL ) according to technical analysis indicators.
- Based on analysis of the Oscillators technical indicator, the current market trend for China Pharma stock suggests that it is a good time to sell or bad time to initiate a fresh position
- Based on analysis of the Moving Averages technical indicator, China Pharma stock is in a uptrend ↗️
- Based on analysis of the Pivot Points, the current market trend for China Pharma stock suggests that it is a good time to sell or bad time to initiate a fresh position
Analysis Summary
Oscillators
Sell
Neutral
Buy
Moving Averages
Sell
Neutral
Buy
Pivots
Sell
Neutral
Buy
Oscillators
Name | Value | Action |
|---|---|---|
Relative Strength Index | 64.62 | Sell |
Stochastic | 69.02, 73.21 | Neutral |
Ultimate Oscillator | 55.04 | Neutral |
Stochastic Relative Strength Index | 93.4, 97.8 | Sell |
Moving Average Convergence Divergence | 0.06, 0.01 | Buy |
Moving Averages
Simple Moving Average
Period (Days) | Value | Action |
|---|---|---|
10 | 1.65 | Buy |
20 | 1.54 | Sell |
50 | 1.64 | Sell |
Exponential Moving Average
Period (Days) | Value | Action |
|---|---|---|
10 | 1.7 | Buy |
20 | 1.62 | Sell |
50 | 1.63 | Sell |
Volume Weighted Moving Average
Period (Days) | Value | Action |
|---|---|---|
10 | 1.77 | Neutral |
20 | 1.71 | Buy |
50 | 1.67 | Buy |
Double Exponential Moving Average
Period (Days) | Value | Action |
|---|---|---|
10 | 1.83 | Buy |
20 | 1.69 | Buy |
50 | 1.58 | Sell |
Triple Exponential Moving Average
Period (Days) | Value | Action |
|---|---|---|
10 | 1.9 | Buy |
20 | 1.79 | Buy |
50 | 1.56 | Sell |
Pivot
Pivot | Value |
|---|---|
Resistance L3 | 2.04 |
Resistance L2 | 1.97 |
Resistance L1 | 1.93 |
Pivot Point | 1.86 |
Support L1 | 1.82 |
Support L2 | 1.74 |
Support L3 | 1.7 |
*Disclaimer: The content present here is for informational purposes only, you should not construe any such information or other material as investment advisory.